Scientists Analyze 267 Receptors That Control Protein Fate in Rare Diseases
Cells constantly control the fate of their proteins. They remove proteins that are worn out or no longer needed, but can also alter their activity, localization, or interactions with other molecules. The post Scientists Analyze 267 Receptors That Control Protein Fate in Rare Diseases appeared first on GEN - Genetic Engineering and Biotechnology News .
A comprehensive catalog of 267 cullin–RING ligase substrate receptors has been created by researchers at the International Institute of Molecular and Cell Biology in Warsaw (IIMCB). The study, titled "Cullin-RING receptors in rare disease biology," was published in Trends in Cell Biology. The catalog reveals that 93 of these receptors are linked to genetic diseases.
The researchers explain that these receptors play a crucial role in controlling the fate of proteins within cells. They can either remove worn-out proteins, alter their activity, or change their localization and interactions with other molecules. The ubiquitin–proteasome system is a key player in this process, tagging proteins with ubiquitin for degradation or regulation. Cullin–RING ligases, the largest family of E3 enzymes, attach these tags with precision.
The IIMCB scientists focused on the role of these receptors in genetic diseases, analyzing data on their function, tissue expression, and associations with various diseases. Their findings indicate that neurodevelopmental and neuromuscular symptoms are frequently linked to diseases caused by these receptors, despite most receptors not showing clear tissue-specific expression.
This suggests that the clinical presentation cannot be attributed solely to the sites of protein expression. Other factors may include the substrates recognized by the receptors, gene activity during development, the susceptibility of specific cell types, gene dosage, and the impact of variants on the entire cullin–RING ligase complex.
The catalog serves as a valuable resource for researchers studying rare diseases and the ubiquitin–proteasome system. It can help identify potential disease genes, interpret patient variants, and investigate why different mutations in the same gene can lead to varying symptoms and disease courses. The catalog may also aid in understanding the networks between receptors, their substrates, and other ligases, which is essential for comprehending why cells can sometimes compensate for mutation effects while in other cases disease develops.
Written by urgent.news from GEN Biotechnology's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
